Loading clinical trials...
Loading clinical trials...
A Multicentre, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the Vivasure PerQseal® Closure Device System When Used to Achieve Haemostasis of Common Femoral Arteriotomies Created by 12 to 22 F Sheaths in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures
Conditions
Interventions
PerQseal® Closure Device System
Locations
18
United States
HonorHealth
Scottsdale, Arizona, United States
Scripps
La Jolla, California, United States
Northern Light Eastern Maine Medical Center
Bangor, Maine, United States
Cooper University Hospital
Camden, New Jersey, United States
The Valley Hospital
Paramus, New Jersey, United States
University of Buffalo
Buffalo, New York, United States
Start Date
March 30, 2023
Primary Completion Date
December 16, 2024
Completion Date
June 1, 2025
Last Updated
January 28, 2025
Lead Sponsor
Vivasure Medical Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions